Search tips
Search criteria 


Logo of jclinpathJournal of Clinical PathologyVisit this articleSubmit a manuscriptReceive email alertsContact usBMJ
J Clin Pathol. 1990 October; 43(10): 850–856.
PMCID: PMC502838

Observations on the haemopoietic response to critical illness.


Peripheral blood cytopenias are common in patients receiving intensive care, particularly in those with multiple organ failure. To assess the contribution of bone marrow hypoplasia in such patients 44 bone marrow samples from 24 patients under intensive care were studied by standard morphological techniques and by the granulocyte-macrophage colony forming cell (GM-CFC) assay. Frequently observed morphological abnormalities in the bone marrow included the following: (i) a reduction in overall cellularity in seven patients, with a progressive decrease in most patients studied sequentially; (ii) an increase in the number of actively phagocytic macrophages; and (iii) a disruption of normal bone marrow architecture with the accumulation of intercellular hyaluronic acid glycosaminoglycan. Mean GM-CFC growth was significantly reduced when compared with that in a group of normal controls. In four of five patients studied sequentially GM-CFC growth became subnormal in association with a reduction in bone marrow cellularity. Inhibitory serum factors were not identified. These morphological abnormalities are similar to the changes observed in gelatinous degeneration of the bone marrow. In both situations disruption of the haemopoietic microenvironment, with the accumulation of hyaluronic acid proteoglycan, may be an important factor in the inhibition of haemopoietic progenitor cell growth. The proliferation of macrophages, by the release of a variety of cytokines or reactive oxygen intermediates, may also be implicated in impaired haemopoiesis and the development of disordered erythropoiesis.

Full text

Full text is available as a scanned copy of the original print version. Get a printable copy (PDF file) of the complete article (2.5M), or click on a page image below to browse page by page. Links to PubMed are also available for Selected References.

Images in this article

Click on the image to see a larger version.

Selected References

These references are in PubMed. This may not be the complete list of references from this article.
  • Norwood SH, Civetta JM. Evaluating sepsis in critically ill patients. Chest. 1987 Jul;92(1):137–144. [PubMed]
  • Lee GR. The anemia of chronic disease. Semin Hematol. 1983 Apr;20(2):61–80. [PubMed]
  • Samson D. The anaemia of chronic disorders. Postgrad Med J. 1983 Sep;59(695):543–550. [PMC free article] [PubMed]
  • Lenz G, Goes U, Baron D, Sugg U, Heller W. Red blood cell T-activation and hemolysis in surgical intensive care patients with severe infections. Blut. 1987 Feb;54(2):89–96. [PubMed]
  • Baue AE. Multiple, progressive, or sequential systems failure. A syndrome of the 1970s. Arch Surg. 1975 Jul;110(7):779–781. [PubMed]
  • Border JR, Chenier R, McManamy RH, La Duca J, Seibel R, Birkhahn R, Yu L. Multiple systems organ failure: muscle fuel deficit with visceral protein malnutrition. Surg Clin North Am. 1976 Oct;56(5):1147–1167. [PubMed]
  • Eiseman B, Beart R, Norton L. Multiple organ failure. Surg Gynecol Obstet. 1977 Mar;144(3):323–326. [PubMed]
  • DeCamp MM, Demling RH. Posttraumatic multisystem organ failure. JAMA. 1988 Jul 22;260(4):530–534. [PubMed]
  • Filkins JP. Monokines and the metabolic pathophysiology of septic shock. Fed Proc. 1985 Feb;44(2):300–304. [PubMed]
  • Clowes GH, Jr, George BC, Villee CA, Jr, Saravis CA. Muscle proteolysis induced by a circulating peptide in patients with sepsis or trauma. N Engl J Med. 1983 Mar 10;308(10):545–552. [PubMed]
  • Galvani DW. Cytokines: biological function and clinical use. J R Coll Physicians Lond. 1988 Oct;22(4):226–231. [PubMed]
  • Fibbe WE, Goselink HM, Van Eeden G, Van Damme J, Billiau A, Voogt PJ, Willemze R, Falkenburg JH. Proliferation of myeloid progenitor cells in human long-term bone marrow cultures is stimulated by interleukin-1 beta. Blood. 1988 Oct;72(4):1242–1247. [PubMed]
  • Beutler B, Cerami A. Cachectin: more than a tumor necrosis factor. N Engl J Med. 1987 Feb 12;316(7):379–385. [PubMed]
  • Clark SC, Kamen R. The human hematopoietic colony-stimulating factors. Science. 1987 Jun 5;236(4806):1229–1237. [PubMed]
  • Sieff CA, Niemeyer CM, Mentzer SJ, Faller DV. Interleukin-1, tumor necrosis factor, and the production of colony-stimulating factors by cultured mesenchymal cells. Blood. 1988 Oct;72(4):1316–1323. [PubMed]
  • Fibbe WE, Van Damme J, Billiau A, Duinkerken N, Lurvink E, Ralph P, Altrock BW, Kaushansky K, Willemze R, Falkenburg JH. Human fibroblasts produce granulocyte-CSF, macrophage-CSF, and granulocyte-macrophage-CSF following stimulation by interleukin-1 and poly(rI).poly(rC). Blood. 1988 Sep;72(3):860–866. [PubMed]
  • Ridgway D, Borzy MS, Bagby GC. Granulocyte macrophage colony-stimulating activity production by cultured human thymic nonlymphoid cells is regulated by endogenous interleukin-1. Blood. 1988 Oct;72(4):1230–1236. [PubMed]
  • Mochizuki DY, Eisenman JR, Conlon PJ, Larsen AD, Tushinski RJ. Interleukin 1 regulates hematopoietic activity, a role previously ascribed to hemopoietin 1. Proc Natl Acad Sci U S A. 1987 Aug;84(15):5267–5271. [PubMed]
  • Metcalf D. Detection and analysis of human granulocyte--monocyte precursors using semi-solid cultures. Clin Haematol. 1979 Jun;8(2):263–285. [PubMed]
  • Burgess AW, Wilson EM, Metcalf D. Stimulation by human placental conditioned medium of hemopoietic colony formation by human marrow cells. Blood. 1977 Apr;49(4):573–583. [PubMed]
  • Amos RJ, Amess JA, Hinds CJ, Mollin DL. Incidence and pathogenesis of acute megaloblastic bone-marrow change in patients receiving intensive care. Lancet. 1982 Oct 16;2(8303):835–838. [PubMed]
  • Iozzo RV. Proteoglycans: structure, function, and role in neoplasia. Lab Invest. 1985 Oct;53(4):373–396. [PubMed]
  • Seaman JP, Kjeldsberg CR, Linker A. Gelatinous transformation of the bone marrow. Hum Pathol. 1978 Nov;9(6):685–692. [PubMed]
  • Cornbleet PJ, Moir RC, Wolf PL. A histochemical study of bone marrow hypoplasia in anorexia nervosa. Virchows Arch A Pathol Anat Histol. 1977 Jun 23;374(3):239–247. [PubMed]
  • Mant MJ, Faragher BS. The haematology of anorexia nervosa. Br J Haematol. 1972 Dec;23(6):737–749. [PubMed]
  • Tavassoli M, Eastlund DT, Yam LT, Neiman RS, Finkel H. Gelatinous transformation of bone marrow in prolonged self-induced starvation. Scand J Haematol. 1976 Apr;16(4):311–319. [PubMed]
  • Amrein PC, Friedman R, Kosinski K, Ellman L. Hematologic changes in anorexia nervosa. JAMA. 1979 May 18;241(20):2190–2191. [PubMed]
  • Smith RR, Spivak JL. Marrow cell necrosis in anorexia nervosa and involuntary starvation. Br J Haematol. 1985 Jul;60(3):525–530. [PubMed]
  • Steinberg SE, Nasraway S, Peterson L. Reversal of severe serous atrophy of the bone marrow in anorexia nervosa. JPEN J Parenter Enteral Nutr. 1987 Jul-Aug;11(4):422–423. [PubMed]
  • Wagner S, Wood S, Amess JA. Pancytopenia in a patient receiving home intravenous nutrition. Eur J Clin Nutr. 1988 Dec;42(12):1029–1034. [PubMed]
  • Keating A, Gordon MY. Hierarchical organization of hematopoietic microenvironments: role of proteoglycans. Leukemia. 1988 Nov;2(11):766–769. [PubMed]
  • Gordon MY. Extracellular matrix of the marrow microenvironment. Br J Haematol. 1988 Sep;70(1):1–4. [PubMed]
  • McCuskey RS, Meineke HA, Townsend SF. Studies of the hemopoietic microenvironment. I. Changes in the microvascular system and stroma druing erythropoietic regeneration and suppression in the spleens of CF1 mice. Blood. 1972 May;39(5):697–712. [PubMed]
  • Gordon MY, Riley GP, Watt SM, Greaves MF. Compartmentalization of a haematopoietic growth factor (GM-CSF) by glycosaminoglycans in the bone marrow microenvironment. Nature. 326(6111):403–405. [PubMed]
  • Roberts R, Gallagher J, Spooncer E, Allen TD, Bloomfield F, Dexter TM. Heparan sulphate bound growth factors: a mechanism for stromal cell mediated haemopoiesis. Nature. 1988 Mar 24;332(6162):376–378. [PubMed]
  • Del Rosso M, Cappelletti R, Dini G, Fibbi G, Vannucchi S, Chiarugi V, Guazzelli C. Involvement of glycosaminoglycans in detachment of early myeloid precursors from bone-marrow stromal cells. Biochim Biophys Acta. 1981 Aug 17;676(2):129–136. [PubMed]
  • Oguri K, Okayama E, Caterson B, Okayama M. Isolation, characterization, and localization of glycosaminoglycans in rabbit bone marrow. Blood. 1987 Aug;70(2):501–510. [PubMed]
  • Border JR. Hypothesis: sepsis, multiple systems organ failure, and the macrophage. Arch Surg. 1988 Mar;123(3):285–286. [PubMed]
  • Doran JE, Lundsgaard-Hansen P. Role of the reticuloendothelial system in the pathogenesis of organ damage. Br J Hosp Med. 1988 Mar;39(3):221–225. [PubMed]
  • Nathan CF. Secretory products of macrophages. J Clin Invest. 1987 Feb;79(2):319–326. [PMC free article] [PubMed]
  • Degliantoni G, Murphy M, Kobayashi M, Francis MK, Perussia B, Trinchieri G. Natural killer (NK) cell-derived hematopoietic colony-inhibiting activity and NK cytotoxic factor. Relationship with tumor necrosis factor and synergism with immune interferon. J Exp Med. 1985 Nov 1;162(5):1512–1530. [PMC free article] [PubMed]
  • Broxmeyer HE, Williams DE, Lu L, Cooper S, Anderson SL, Beyer GS, Hoffman R, Rubin BY. The suppressive influences of human tumor necrosis factors on bone marrow hematopoietic progenitor cells from normal donors and patients with leukemia: synergism of tumor necrosis factor and interferon-gamma. J Immunol. 1986 Jun 15;136(12):4487–4495. [PubMed]
  • Clark IA, Chaudhri G. Tumour necrosis factor may contribute to the anaemia of malaria by causing dyserythropoiesis and erythrophagocytosis. Br J Haematol. 1988 Sep;70(1):99–103. [PubMed]
  • Ohkawa M, Shikano T, Ueno N. The effect of monocyte-released oxygen metabolites on colony formation of erythroid progenitor cells. Nihon Ketsueki Gakkai Zasshi. 1986 Sep;49(6):1140–1146. [PubMed]
  • Meagher RC, Salvado AJ, Wright DG. An analysis of the multilineage production of human hematopoietic progenitors in long-term bone marrow culture: evidence that reactive oxygen intermediates derived from mature phagocytic cells have a role in limiting progenitor cell self-renewal. Blood. 1988 Jul;72(1):273–281. [PubMed]
  • Weitberg AB, Weitzman SA, Destrempes M, Latt SA, Stossel TP. Stimulated human phagocytes produce cytogenetic changes in cultured mammalian cells. N Engl J Med. 1983 Jan 6;308(1):26–30. [PubMed]
  • Reid CD, Baptista LC, Deacon R, Chanarin I. Megaloblastic change is a feature of colonies derived from an early erythroid progenitor (BFU-E) stimulated by monocytes in culture. Br J Haematol. 1981 Dec;49(4):551–561. [PubMed]

Articles from Journal of Clinical Pathology are provided here courtesy of BMJ Group